J Knee Surg 2022; 35(02): 128-134
DOI: 10.1055/s-0040-1713355
Original Article

Comparative Analysis on the Effects of Sarcopenia following Primary Total Knee Arthroplasty: A Retrospective Matched-Control Analysis

Andrew D. Ardeljan
1   Division of Health Professions, Nova Southeastern College of Osteopathic Medicine, Ft. Lauderdale, Florida
2   Orthopaedic Research Department, Holy Cross Orthopaedic Research Institute, Ft. Lauderdale, Florida
,
Teja S. Polisetty
2   Orthopaedic Research Department, Holy Cross Orthopaedic Research Institute, Ft. Lauderdale, Florida
3   Harvard Medical School, Harvard University, Boston, Massachusetts
,
Joseph Palmer
4   Department of Orthopaedic Surgery, Broward Health Medical Center, Ft. Lauderdale, Florida
,
2   Orthopaedic Research Department, Holy Cross Orthopaedic Research Institute, Ft. Lauderdale, Florida
,
Martin W. Roche
2   Orthopaedic Research Department, Holy Cross Orthopaedic Research Institute, Ft. Lauderdale, Florida
› Author Affiliations

Abstract

Despite the high incidence of sarcopenia in the orthopaedic community, studies evaluating the influence of sarcopenia following primary total knee arthroplasty (TKA) are limited. Therefore, the purpose of this study is to determine if sarcopenic patients undergoing primary TKA have higher rates of (1) in-hospital lengths of stay (LOS); (2) medical complications; (3) implant-related complications; (4) fall risk; (5) lower extremity fracture risk; and (6) costs of care. Sarcopenia patients were matched to controls in a 1:5 ratio according to age, sex, and medical comorbidities. The query yielded 90,438 patients with (n = 15,073) and without (n = 75,365) sarcopenia undergoing primary TKA. Primary outcomes analyzed included: in-hospital LOS, 90-day medical complications, 2-year implant-related complications, fall risk, lower extremity fracture risk, and costs of care. A p-value of less than 0.05 was considered statistically significant. Patients with sarcopenia undergoing primary TKA had greater in-hospital LOS (4 vs. 3 days, p < 0.0001). Sarcopenic patients were also found to have increased incidence and odds of 90-day medical complications (2.9 vs. 1.1%; odds ratio [OR] = 2.83, p < 0.0001), falls (0.9 vs. 0.3%; OR = 3.54, p < 0.0001), lower extremity fractures (1.0 vs. 0.2%; OR = 5.54, p < 0.0001), and reoperation (0.9 vs. 0.5%; OR = 1.87, p < 0.0001). Additionally, sarcopenic patients had greater 2-year implant-related complications (4.3 vs. 2.4%; OR = 1.80, p < 0.0001), as well as day of surgery ($52,900 vs. 48,248, p < 0.0001), and 90-day ($68,303 vs. $57,671, p < 0.0001) costs compared with controls. This analysis of over 90,000 patients demonstrates that patients with sarcopenia undergoing primary TKA have greater in-hospital LOS, increased odds of 90-day medical complications, falls, lower extremity fractures, and reoperations. Additionally, sarcopenia was associated with greater 2-year implant-related complications, day of surgery costs, and 90-day costs. The study is useful as it can allow orthopaedic surgeons to properly educate these patients of the potential complications which may occur following their surgery.



Publication History

Received: 03 February 2020

Accepted: 02 May 2020

Article published online:
06 July 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Cruz-Jentoft AJ, Baeyens JP, Bauer JM. et al; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010; 39 (04) 412-423
  • 2 Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc 2016; 17 (08) 675-677
  • 3 Li M, Kong Y, Chen H, Chu A, Song G, Cui Y. Accuracy and prognostic ability of the SARC-F questionnaire and Ishii's score in the screening of sarcopenia in geriatric inpatients. Braz J Med Biol Res 2019; 52 (09) e8204
  • 4 Bokshan SL, DePasse JM, Daniels AH. Sarcopenia in orthopedic surgery. Orthopedics 2016; 39 (02) e295-e300
  • 5 Jochum SB, Kistner M, Wood EH. et al. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer. Colorectal Dis 2019; 21 (12) 1372-1378
  • 6 Zhang X, Huang P, Dou Q. et al. Falls among older adults with sarcopenia dwelling in nursing home or community: a meta-analysis. Clin Nutr 2020; 39 (01) 33-39
  • 7 Mayhew AJ, Amog K, Phillips S. et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 2019; 48 (01) 48-56
  • 8 Landi F, Liperoti R, Russo A. et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31 (05) 652-658
  • 9 Goates S, Du K, Arensberg MB, Gaillard T, Guralnik J, Pereira SL. Economic impact of hospitalizations in us adults with sarcopenia. J Frailty Aging 2019; 8 (02) 93-99
  • 10 Basualto-Alarcón C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and androgens: a link between pathology and treatment. Front Endocrinol (Lausanne) 2014; 5: 217
  • 11 Wall BT, Gorissen SH, Pennings B. et al. Aging is accompanied by a blunted muscle protein synthetic response to protein ingestion. PLoS One 2015; 10 (11) e0140903
  • 12 Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 2016; 229 (02) R67-R81
  • 13 Coelho-Júnior HJ, Rodrigues B, Uchida M, Marzetti E. Low protein intake is associated with frailty in older adults: a systematic review and meta-analysis of observational studies. Nutrients 2018; 10 (09) E1334
  • 14 Gianoudis J, Bailey CA, Daly RM. Associations between sedentary behaviour and body composition, muscle function and sarcopenia in community-dwelling older adults. Osteoporos Int 2015; 26 (02) 571-579
  • 15 von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 2010; 1 (02) 129-133
  • 16 Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13 (08) 708-712
  • 17 Lardiés-Sánchez B, Sanz-París A. Sarcopenia and malnutrition in the elderly. In: Dionyssiotis Y. ed. Frailty and Sarcopenia—Onset, Development and Clinical Challenges. Rijeka, Croatia: InTech; 2017: 71-80
  • 18 Limpawattana P, Inthasuwan P, Putraveephong S, Boonsawat W, Theerakulpisut D, Sawanyawisuth K. Sarcopenia in chronic obstructive pulmonary disease: a study of prevalence and associated factors in the Southeast Asian population. Chron Respir Dis 2018; 15 (03) 250-257
  • 19 Law TD, Clark LA, Clark BC. Resistance exercise to prevent and manage sarcopenia and dynapenia. Annu Rev Gerontol Geriatr 2016; 36 (01) 205-228
  • 20 Ji H-M, Won Y-Y, Kang BM, Park Y-S, Han MH. Sarcopenia in patients scheduled to undergo orthopaedic surgery. Bone Abstract 2014; 3: PP204
  • 21 Friedman J, Lussiez A, Sullivan J, Wang S, Englesbe M. Implications of sarcopenia in major surgery. Nutr Clin Pract 2015; 30 (02) 175-179
  • 22 Logerstedt D, Lynch A, Axe MJ, Snyder-Mackler L. Pre-operative quadriceps strength predicts IKDC2000 scores 6 months after anterior cruciate ligament reconstruction. Knee 2013; 20 (03) 208-212
  • 23 Di Monaco M, Castiglioni C, De Toma E, Gardin L, Giordano S, Tappero R. Handgrip strength is an independent predictor of functional outcome in hip-fracture women: a prospective study with 6-month follow-up. Medicine (Baltimore) 2015; 94 (06) e542
  • 24 Mizner RL, Petterson SC, Snyder-Mackler L. Quadriceps strength and the time course of functional recovery after total knee arthroplasty. J Orthop Sports Phys Ther 2005; 35 (07) 424-436
  • 25 Savino E, Martini E, Lauretani F. et al. Handgrip strength predicts persistent walking recovery after hip fracture surgery. Am J Med 2013; 126 (12) 1068-75.e1
  • 26 Yoshida Y, Mizner RL, Ramsey DK, Snyder-Mackler L. Examining outcomes from total knee arthroplasty and the relationship between quadriceps strength and knee function over time. Clin Biomech (Bristol, Avon) 2008; 23 (03) 320-328
  • 27 Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample. J Rheumatol 2019; 46 (09) 1134-1140
  • 28 Cancienne JM, Dempsey IJ, Holzgrefe RE, Brockmeier SF, Werner BC. Is hepatitis C infection associated with a higher risk of complications after total shoulder arthroplasty?. Clin Orthop Relat Res 2016; 474 (12) 2664-2669
  • 29 Yoshihara H, Yoneoka D. Understanding the statistics and limitations of large database analyses. Spine 2014; 39 (16) 1311-1312
  • 30 Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107 (06) 931-936
  • 31 Krell RW, Kaul DR, Martin AR. et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19 (12) 1396-1402
  • 32 Bokshan SL, Han AL, DePasse JM. et al. Effect of sarcopenia on postoperative morbidity and mortality after thoracolumbar spine surgery. Orthopedics 2016; 39 (06) e1159-e1164
  • 33 Bokshan SL, Han A, DePasse JM, Marcaccio SE, Eltorai AEM, Daniels AH. Inpatient costs and blood transfusion rates of sarcopenic patients following thoracolumbar spine surgery. J Neurosurg Spine 2017; 27 (06) 676-680
  • 34 Ortiz A, Sanchez-Niño MD. Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J 2019; 12 (01) 110-112
  • 35 Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 2017; 26 (03) 219-228
  • 36 Pereira RA, Cordeiro AC, Avesani CM. et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 2015; 30 (10) 1718-1725
  • 37 Kim J-K, Choi SR, Choi MJ. et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2014; 33 (01) 64-68
  • 38 Avin KG, Chen NX, Organ JM. et al. Skeletal muscle regeneration and oxidative stress are altered in chronic kidney disease. PLoS One 2016; 11 (08) e0159411
  • 39 Cigarrán S, Pousa M, Castro MJ. et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J Ren Nutr 2013; 23 (05) e89-e95
  • 40 Lanzoni LG, Morales A, Aziz Silveira CG. et al. Evaluation of sarcopenia in patients with acute kidney injury: use of serum biomarkers. FASEB J 32 (Suppl. 01) 849.9
  • 41 Altuna-Venegas S, Aliaga-Vega R, Maguiña JL, Parodi JF, Runzer-Colmenares FM. Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015. Arch Gerontol Geriatr 2019; 82: 100-105
  • 42 Robbins J, Bridges AD, Taylor A. Oral, pharyngeal and esophageal motor function in aging. Accessed October 15, 2019 at: https://www.nature.com/gimo/contents/pt1/full/gimo39.html
  • 43 Matsumoto H, Tanimura C, Tanishima S, Osaki M, Noma H, Hagino H. Sarcopenia is a risk factor for falling in independently living Japanese older adults: A 2-year prospective cohort study of the GAINA study. Geriatr Gerontol Int 2017; 17 (11) 2124-2130
  • 44 Babu JM, Kalagara S, Durand W, Antoci V, Deren ME, Cohen E. Sarcopenia as a risk factor for prosthetic infection after total hip or knee arthroplasty. J Arthroplasty 2019; 34 (01) 116-122
  • 45 Grace JN, Sim FH. Fracture of the patella after total knee arthroplasty. Clin Orthop Relat Res 1988; (230) 168-175
  • 46 Windsor RE, Scuderi GR, Insall JN. Patellar fractures in total knee arthroplasty. J Arthroplasty 1989; 4 (suppl): S63-S67
  • 47 Weber D, Peter RE. Distal femoral fractures after knee arthroplasty. Int Orthop 1999; 23 (04) 236-239
  • 48 Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165 (07) 867-903
  • 49 Rello J, Ollendorf DA, Oster G. et al; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122 (06) 2115-2121
  • 50 Warren DK, Shukla SJ, Olsen MA. et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31 (05) 1312-1317
  • 51 Blanchette CM, Wang PF, Joshi AV, Asmussen M, Saunders W, Kruse P. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 2007; 16 (03) 353-363
  • 52 Alp E, Cevahir F, Ersoy S, Guney A. Incidence and economic burden of prosthetic joint infections in a university hospital: a report from a middle-income country. J Infect Public Health 2016; 9 (04) 494-498